Doximity Inc
NYSE:DOCS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.99
61.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Doximity Inc
Wall Street
Price Targets
DOCS Price Targets Summary
Doximity Inc
According to Wall Street analysts, the average 1-year price target for
DOCS
is 57.54 USD
with a low forecast of 31.31 USD and a high forecast of 78.75 USD.
DOCS Last Price Targets
Doximity Inc
The latest public price target was made on Nov 14, 2024 by
Jailendra Singh
from
Truist Financial
,
who expects
DOCS
stock to
drop by 15%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jailendra Singh
Truist Financial
|
49
USD
Downside 15% |
1 month ago
Nov 14, 2024
|
Doximity Inc (DOCS) PT Raised to $49 at Truist Securities
StreetInsider
|
Richard Close
Canaccord Genuity
|
60
USD
Upside 4% |
1 month ago
Nov 13, 2024
|
Canaccord Genuity Downgrades Doximity Inc (DOCS) to Hold
StreetInsider
|
Stan Berenshteyn
Wells Fargo
|
41
USD
Downside 29% |
1 month ago
Nov 8, 2024
|
Wells Fargo Upgrades Doximity Inc (DOCS) to Equal Weight
StreetInsider
|
Scott Berg
Needham
|
65
USD
Upside 12% |
1 month ago
Nov 8, 2024
|
Doximity Inc (DOCS) PT Raised to $65 at Needham
StreetInsider
|
Scott Schoenhaus
KeyBanc
|
70
USD
Upside 21% |
1 month ago
Nov 8, 2024
|
KeyBanc Upgrades Doximity Inc (DOCS) to Overweight
StreetInsider
|
Stephanie Davis
Barclays
|
52
USD
Downside 10% |
2 months ago
Oct 15, 2024
|
Barclays Upgrades Doximity Inc (DOCS) to Overweight, 'Sales Made Simple'
StreetInsider
|
Elizabeth Anderson
Evercore ISI
|
45
USD
Downside 22% |
2 months ago
Oct 8, 2024
|
Doximity price target raised to $45 from $34 at Evercore ISI
TheFly
|
Allen Lutz
Bank of America Securities
|
45
USD
Downside 22% |
2 months ago
Oct 7, 2024
|
Doximity price target raised to $45 from $32 at BofA
TheFly
|
|
Scott Berg
Needham
|
38
USD
Downside 34% |
4 months ago
Aug 9, 2024
|
Needham Upgrades Doximity Inc (DOCS) to Buy
StreetInsider
|
|
Elizabeth Anderson
Evercore ISI
|
29
USD
Downside 50% |
7 months ago
May 17, 2024
|
Doximity Inc (DOCS) PT Raised to $29 at Evercore ISI
StreetInsider
|
|
Stephanie Davis
Barclays
|
31
USD
Downside 46% |
7 months ago
May 17, 2024
|
Barclays Reiterates Equalweight Rating on Doximity Inc (DOCS)
StreetInsider
|
|
Jailendra Singh
Truist Financial
|
31
USD
Downside 46% |
7 months ago
May 17, 2024
|
Doximity Inc (DOCS) PT Raised to $31 at Truist Securities
StreetInsider
|
Craig Hettenbach
Morgan Stanley
|
25
USD
Downside 57% |
8 months ago
Apr 23, 2024
|
Doximity checks point to 'tepid growth,' says Morgan Stanley
TheFly
|
|
Elizabeth Anderson
Evercore ISI
|
30
USD
Downside 48% |
8 months ago
Apr 1, 2024
|
Evercore ISI Reacts to Jehoshaphat Research Report on Doximity Inc (DOCS): 'the determination of declining growth appears premature'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DOCS's stock price target?
Price Target
57.54
USD
According to Wall Street analysts, the average 1-year price target for
DOCS
is 57.54 USD
with a low forecast of 31.31 USD and a high forecast of 78.75 USD.
What is Doximity Inc's Revenue forecast?
Projected CAGR
12%
For the last 4 years the
compound annual growth rate for
Doximity Inc's revenue is
42%.
The projected
CAGR
for the next 3 years is
12%.
What is Doximity Inc's Operating Income forecast?
Projected CAGR
26%
For the last 4 years the
compound annual growth rate for
Doximity Inc's operating income is
67%.
The projected
CAGR
for the next 3 years is
26%.
What is Doximity Inc's Net Income forecast?
Projected CAGR
21%
For the last 4 years the
compound annual growth rate for
Doximity Inc's net income is
92%.
The projected
CAGR
for the next 3 years is
21%.
You don't have any saved screeners yet
